Enhanced weight loss following pramlintide/metreleptin combination treatment in obese subjects: clinical evidence for restoration of leptin responsiveness by amylin agonism

被引：0
|
作者：
Koda, J. [1 ]
Weyer, C. [1 ]
Smith, S. [2 ]
Ravussin, E. [2 ]
Mitchell, J.
Kesty, N. [1 ]
Shan, K. [1 ]
Baron, A. [1 ]
机构：
[1] Amylin Pharmaceut Inc, San Diego, CA USA
[2] Louisiana State Univ, Baton Rouge, LA 70803 USA
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
83
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 11 条
  • [1] Enhanced weight loss following pramlintide/metreleptin combination treatment in obese subjects: Clinical evidence for restoration of leptin responsiveness by amylin agonism
    Weyer, Christian
    Koda, Joy
    Smith, Steve
    Ravus-Sin, Eric
    Mitchell, Julie
    Kesty, Nicole C.
    Shan, Kevin
    Baron, Alain
    DIABETES, 2008, 57 : A482 - A482
  • [2] Enhanced Weight Loss Following Pramlintide/Metreleptin Combination Treatment in Overweight and Obese Subjects is Accompanied by Improved Control of Eating
    Smith, Steven R.
    Blundell, John
    Ravussin, Eric
    Mitchell, Julie
    Kesty, Nicole
    Shan, Kevin
    Koda, Joy
    Weyer, Christian
    OBESITY, 2008, 16 : S64 - S65
  • [3] Enhanced weight loss following co-administration of pramlintide with sibutramine or phentermine in obese subjects
    Halseth, A.
    Aronne, L.
    Burns, C.
    Porter, L.
    Shen, L.
    DIABETOLOGIA, 2008, 51 : S318 - S318
  • [4] Enhanced weight loss following co-administration of pramlintide with sibutramine or phentermine in obese subjects
    Aronne, Louis J.
    Halseth, Amy
    Burns, Colleen
    Porter, Lisa
    Shen, Larry
    DIABETES, 2008, 57 : A30 - A31
  • [5] Characterization of obese subjects achieving 5% or greater weight loss after 16 weeks of treatment with the amylin analog pramlintide
    Fujioka, K
    Aronne, L
    Chen, K
    Lush, C
    Halseth, A
    Wang, Y
    Burns, C
    Mckay, R
    Weyer, C
    OBESITY RESEARCH, 2005, 13 : A193 - A193
  • [6] Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
    Roth, Jonathan D.
    Roland, Barbara L.
    Cole, Rebecca L.
    Trevaskis, James L.
    Weyer, Christian
    Koda, Joy E.
    Anderson, Christen M.
    Parkes, David G.
    Baron, Alain D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (20) : 7257 - 7262
  • [7] Changes in Weight and Binge Eating Scale Scores in Obese Subjects Treated with Pramlintide as Monotherapy and in Combination with Oral Weight Loss Agents
    Velez, Fulton
    Blundell, John
    Burns, Colleen
    Kesty, Nicole
    Best, Jennie H.
    Halseth, Amy
    OBESITY, 2008, 16 : S219 - S219
  • [8] Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: A phase 2, randomized, placebo-controlled, dose-escalation study
    Aronne, Louis
    Fujioka, Ken
    Aroda, Vanita
    Chen, Kim
    Halseth, Amy
    Kesty, Nicole C.
    Burns, Colleen
    Lush, Cameron W.
    Weyer, Christian
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08): : 2977 - 2983
  • [9] Effect of vitamin D supplementation in combination with weight loss diet on lipid profile and sirtuin 1 in obese subjects with vitamin D deficiency: a double blind randomized clinical trial
    Aliashrafi, Soodabeh
    Rafie-Arefhosseini, Seyed
    Lotfi-Dizaji, Lida
    Ebrahimi-Mameghani, Mehrangiz
    HEALTH PROMOTION PERSPECTIVES, 2019, 9 (04): : 263 - 269
  • [10] Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naive Type 2 Diabetes following Equivalent Weight Loss
    Straznicky, Nora E.
    Grima, Mariee T.
    Sari, Carolina I.
    Lambert, Elisabeth A.
    Phillips, Sarah E.
    Eikelis, Nina
    Mariani, Justin A.
    Kobayashi, Daisuke
    Hering, Dagmara
    Dixon, John B.
    Lambert, Gavin W.
    FRONTIERS IN PHYSIOLOGY, 2016, 7
12